Literature DB >> 26582474

The cytoplasmic domain is essential for transport function of the integral membrane transport protein SLC4A11.

Sampath K Loganathan1, Chris M Lukowski1, Joseph R Casey2.   

Abstract

Large cytoplasmic domains (CD) are a common feature among integral membrane proteins. In virtually all cases, these CD have a function (e.g., binding cytoskeleton or regulatory factors) separate from that of the membrane domain (MD). Strong associations between CD and MD are rare. Here we studied SLC4A11, a membrane transport protein of corneal endothelial cells, the mutations of which cause genetic corneal blindness. SLC4A11 has a 41-kDa CD and a 57-kDa integral MD. One disease-causing mutation in the CD, R125H, manifests a catalytic defect, suggesting a role of the CD in transport function. Expressed in HEK-293 cells without the CD, MD-SLC4A11 is retained in the endoplasmic reticulum, indicating a folding defect. Replacement of CD-SLC4A11 with green fluorescent protein did not rescue MD-SLC4A11, suggesting some specific role of CD-SLC4A11. Homology modeling revealed that the structure of CD-SLC4A11 is similar to that of the Cl(-)/HCO3(-) exchange protein AE1 (SLC4A1) CD. Fusion to CD-AE1 partially rescued MD-SLC4A11 to the cell surface, suggesting that the structure of CD-AE1 is similar to that of CD-SLC4A11. The CD-AE1-MD-SLC4a11 chimera, however, had no functional activity. We conclude that CD-SLC4A11 has an indispensable role in the transport function of SLC4A11. CD-SLC4A11 forms insoluble precipitates when expressed in bacteria, suggesting that the domain cannot fold properly when expressed alone. Consistent with a strong association between CD-SLC4A11 and MD-SLC4A11, these domains specifically associate when coexpressed in HEK-293 cells. We conclude that SLC4A11 is a rare integral membrane protein in which the CD has strong associations with the integral MD, which contributes to membrane transport function.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  SLC4A11; corneal dystrophy; cytoplasmic domain; membrane domain; protein misfolding

Mesh:

Substances:

Year:  2015        PMID: 26582474      PMCID: PMC4719032          DOI: 10.1152/ajpcell.00246.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  51 in total

1.  Oligomerization of SLC4A11 protein and the severity of FECD and CHED2 corneal dystrophies caused by SLC4A11 mutations.

Authors:  Gonzalo L Vilas; Sampath K Loganathan; Anita Quon; Periasamy Sundaresan; Eranga N Vithana; Joseph Casey
Journal:  Hum Mutat       Date:  2011-12-20       Impact factor: 4.878

2.  A substrate access tunnel in the cytosolic domain is not an essential feature of the solute carrier 4 (SLC4) family of bicarbonate transporters.

Authors:  Volodymyr Shnitsar; Jing Li; Xuyao Li; Charles Calmettes; Arghya Basu; Joseph R Casey; Trevor F Moraes; Reinhart A F Reithmeier
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

3.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

4.  Two novel mutations including a large deletion of the SLC4A11 gene causing autosomal recessive hereditary endothelial dystrophy.

Authors:  Vilavun Puangsricharern; Patra Yeetong; Chonthicha Charumalai; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  Br J Ophthalmol       Date:  2014-08-19       Impact factor: 4.638

5.  Three-dimensional model for the human Cl-/HCO3- exchanger, AE1, by homology to the E. coli ClC protein.

Authors:  Pamela Bonar; Hans-Peter Schneider; Holger M Becker; Joachim W Deitmer; Joseph R Casey
Journal:  J Mol Biol       Date:  2013-04-11       Impact factor: 5.469

6.  SLC4A11 is an EIPA-sensitive Na(+) permeable pHi regulator.

Authors:  Diego G Ogando; Supriya S Jalimarada; Wenlin Zhang; Eranga N Vithana; Joseph A Bonanno
Journal:  Am J Physiol Cell Physiol       Date:  2013-07-17       Impact factor: 4.249

7.  Biosynthetic and functional defects in newly identified SLC4A11 mutants and absence of COL8A2 mutations in Fuchs endothelial corneal dystrophy.

Authors:  Nagasamy Soumittra; Sampath K Loganathan; Dharanija Madhavan; Vedam L Ramprasad; Tharigopala Arokiasamy; Sundaram Sumathi; Thirumalai Karthiyayini; Sudhir R Rachapalli; Govindasamy Kumaramanickavel; Joseph R Casey; Rama Rajagopal
Journal:  J Hum Genet       Date:  2014-07-10       Impact factor: 3.172

8.  Corneal dystrophy-causing SLC4A11 mutants: suitability for folding-correction therapy.

Authors:  Sampath K Loganathan; Joseph R Casey
Journal:  Hum Mutat       Date:  2014-06-28       Impact factor: 4.878

Review 9.  Mutation analysis of the SLC4A11 gene in Indian families with congenital hereditary endothelial dystrophy 2 and a review of the literature.

Authors:  Srinivas Gopinath Kodaganur; Saketh Kapoor; Avinash M Veerappa; Sagar Jagannath Tontanahal; Astha Sarda; S Yathish; D Ravi Prakash; Arun Kumar
Journal:  Mol Vis       Date:  2013-08-02       Impact factor: 2.367

10.  Transmembrane water-flux through SLC4A11: a route defective in genetic corneal diseases.

Authors:  Gonzalo L Vilas; Sampath K Loganathan; Jun Liu; Andri K Riau; James D Young; Jodhbir S Mehta; Eranga N Vithana; Joseph R Casey
Journal:  Hum Mol Genet       Date:  2013-06-27       Impact factor: 6.150

View more
  10 in total

1.  Functional assessment of SLC4A11, an integral membrane protein mutated in corneal dystrophies.

Authors:  Sampath K Loganathan; Hans-Peter Schneider; Patricio E Morgan; Joachim W Deitmer; Joseph R Casey
Journal:  Am J Physiol Cell Physiol       Date:  2016-08-24       Impact factor: 4.249

2.  SLC4A11 mutations causative of congenital hereditary endothelial dystrophy (CHED) progressing to Harboyan syndrome in consanguineous Pakistani families.

Authors:  Sabika Firasat; Wajid Ali Khan; Ume Sughra; Haiba Kaul; Shagufta Naz; Bushra Noreen; Rutaba Gul; Kiran Afshan
Journal:  Mol Biol Rep       Date:  2021-10-12       Impact factor: 2.316

3.  Corneal dystrophy mutations R125H and R804H disable SLC4A11 by altering the extracellular pH dependence of the intracellular pK that governs H+(OH-) transport.

Authors:  Bianca N Quade; Aniko Marshall; Mark D Parker
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-22       Impact factor: 5.282

4.  Vps35-deficiency impairs SLC4A11 trafficking and promotes corneal dystrophy.

Authors:  Wei Liu; Fu-Lei Tang; Sen Lin; Kai Zhao; Lin Mei; Jian Ye; Wen-Cheng Xiong
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

5.  SLC4A11 depletion impairs NRF2 mediated antioxidant signaling and increases reactive oxygen species in human corneal endothelial cells during oxidative stress.

Authors:  Sanjukta Guha; Sunita Chaurasia; Charanya Ramachandran; Sanhita Roy
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

6.  Ammonia sensitive SLC4A11 mitochondrial uncoupling reduces glutamine induced oxidative stress.

Authors:  Diego G Ogando; Moonjung Choi; Rajalekshmy Shyam; Shimin Li; Joseph A Bonanno
Journal:  Redox Biol       Date:  2019-06-23       Impact factor: 11.799

7.  Human Corneal Expression of SLC4A11, a Gene Mutated in Endothelial Corneal Dystrophies.

Authors:  Darpan Malhotra; Sampath K Loganathan; Anthony M Chiu; Chris M Lukowski; Joseph R Casey
Journal:  Sci Rep       Date:  2019-07-04       Impact factor: 4.379

8.  Altered gene expression in slc4a11-/- mouse cornea highlights SLC4A11 roles.

Authors:  Bernardo V Alvarez; Marilyse Piché; Carolin Aizouki; Fariha Rahman; Jonathan M J Derry; Isabelle Brunette; Joseph R Casey
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379

9.  Human SLC4A11 does not complement BOR1 or support borate transport in Saccharomyces cerevisiae.

Authors:  Jean L Beltran; Richara K Bain; Marie J Stiefel; Alexis S McDonnell; Natalie N Carr; Bryan H Thurtle-Schmidt
Journal:  MicroPubl Biol       Date:  2022-07-20

Review 10.  The H+ Transporter SLC4A11: Roles in Metabolism, Oxidative Stress and Mitochondrial Uncoupling.

Authors:  Joseph A Bonanno; Raji Shyam; Moonjung Choi; Diego G Ogando
Journal:  Cells       Date:  2022-01-07       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.